SIGN UP

April 19, 2024 10:45 AM EDT

Histogen files for bankruptcy; Barinthus Bio shares Ph1b/2 data for HPV treatment

ENDPOINTS

Plus, news about TScan Therapeutics:

Histogen files for Chapter 11 bankruptcy: The biotech, which stopped work in September,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

Updated: Novo’s 23% weight loss with CagriSema falls short of high expectations, new trial planned

FDA approves Humacyte’s lab-grown blood vessels in milestone for regenerative medicine

Califf, on his way out at FDA, predicts agency tug-of-war between Ramaswamy and RFK Jr.

Accelerated approval brings Pfizer's BRAF inhibitor to first-line patients

Sofinnova outlines $550M fund after IPOs and M&A deals